Clinical Trials Logo

Female Contraception clinical trials

View clinical trials related to Female Contraception.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04143659 Recruiting - Healthy Women Clinical Trials

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

Start date: March 3, 2020
Phase: Phase 1
Study type: Interventional

This is a Phase I multicenter, open-label, dose-ranging, three-dose PK and PD study of injectable LB administered as an IM or SQ injection at 40 mg, and subsequently at 50mg SQ and then 60 mg SQ depending on the preliminary pharmacokinetic and pharmacodynamic results obtained with 40 mg dosing.

NCT ID: NCT03432416 Recruiting - Healthy Women Clinical Trials

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Start date: February 12, 2018
Phase: Phase 2
Study type: Interventional

This will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of Nestorone® and estradiol (NES-E2 CVR).

NCT ID: NCT02257671 Recruiting - Clinical trials for Female Contraception

Oral Contraceptives and Economic Behaviour

P-piller101
Start date: February 2012
Phase: N/A
Study type: Interventional

The investigators aim is to evaluate effects of combined oral contraceptives (OC) on mood, sexuality and economic behaviour in a randomized, double-blind, placebo-controlled study. 400 healthy women will be randomized to OC or placebo for a period of three months. Before and at the end of treatment, mood and sexuality will be assessed by validated instruments. At the end of treatment, each woman will participate in behavioral experiments testing self-confidence, risk taking and altruism. The current project could fill the gap of ignorance about causal effects of OCs on mood, sexuality and behavior. The results might improve current practice as regards information about OCs, choice of hormonal contraceptive, regimen and duration of use. As a consequence, this could lead to reduced discontinuation rate, fewer unintended pregnancies and abortions. The project will contribute to an overall improvement in women's reproductive health.